InforMedix and McKesson BioServices Co-Present Their Integrated Technology Platform for Clinical Studies at CSSG Conference.ROCKVILLE, Md. -- Alliance Partners Present Novel Solution to Pharmaceutical and Biotechnology Representatives InforMedix Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB: IFMX IFMX Informix Corporation ) announced today that InforMedix and McKesson BioServices, presented "How Technology Can Improve Medication and Protocol Compliance in Clinical Trials" at the Clinical Supplies Support Group (CSSG CSSG Combat Service Support Group (USMC) CSSG Communications Software Solutions Group (Tekelec) CSSG Competition Strategy Steering Group ) meeting, held in Gaithersburg, Maryland. Attendees included representatives from major pharmaceutical and biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. , and research institutes, including Merck, Johnson & Johnson, Novartis, Endo Pharmaceuticals Endo became Endo Pharmaceuticals Inc. as a result of a management buyout from DuPont Merck in 1997. Endo is a specialty pharmaceutical company engaged in the research, development, sale and marketing of prescription pharmaceuticals used primarily to treat and manage pain. , Human Genome Sciences Human Genome Sciences NASDAQ: HGSI is a biopharmaceutical corporation founded in 1992. Its stated purpose is to "discover, develop, manufacture and market innovative drugs that serve patients with unmet medical needs, with a primary focus on protein and antibody drugs. , MedImmune, Organon or·ga·non or or·ga·num n. pl. or·ga·nons or or·ga·nums or or·ga·na 1. An organ. 2. A set of principles for use in scientific investigation. organon pl. organa [Gr.] organ. , Sepracor, Quintiles Quintiles Transnational Corp. is a contract research organization which serves the pharmaceutical, biotechnology and healthcare industries. History Quintiles was founded in 1982 by Dennis Gillings and as of 2007 it has 18,000 employees. , and the National Cancer Institute. The presentation focused on how the integrated delivery platform combines InforMedix's electronic hand-held patient monitoring device with McKesson BioService's clinical trial drug packaging design, to help optimize monitoring of patient medication compliance and data-gathering in large organized clinical studies. Randy Dulin, InforMedix Senior Vice President, and Joa Haas, McKesson BioServices regional sales manager sales manager n → gerente m/f de ventas sales manager n → directeur commercial sales manager sale n → gave the joint presentation. Marty Jeiven, MS, RPh, President of Jeiven Pharmaceutical Consulting, Inc., the organizer of the event, stated, "Non-compliant patients can confound con·found tr.v. con·found·ed, con·found·ing, con·founds 1. To cause to become confused or perplexed. See Synonyms at puzzle. 2. accurate data capture in large clinical trials, adding unnecessary time and expense. The InforMedix/McKesson BioServices team addressed how their novel platform solution may aid in improving medication compliance and protocol adherence, as well as streamlining the process of remote patient data-gathering. Mr. Dulin and Ms. Haas addressed how the use of real-time patient monitoring technology enables high-quality dose-response data capture." Through a recently announced strategic alliance between McKesson and InforMedix, McKesson BioServices' specialty clinical trial material packaging has been combined with InforMedix's Med-eMonitor(TM) and Med-eXpert Systems(TM), to provide the first integrated solution to the clinical trials market that manages medication administration, patient medication compliance and safety, and the simultaneous capture of electronic diary data. The first clinical study to use this integrated solution was also recently announced, a pioneering study of remote rural diabetic patients to monitor their responses to medication, including the relationship between medication compliance, blood glucose blood glucose Diabetology The principal sugar produced by the body from food–especially carbohydrates, but also from proteins and fats; glucose is the body's major source of energy, is transported to cells via the circulation and used by cells in the presence and HbA1c levels, at St. Vincent Healthcare, Billings Montana. St. Vincent is the network hub See hub and hub vs. switch. for the Partners in Health Telemedicine Network, which has global connectivity capabilities, and also has tested telemedicine equipment used by NASA NASA: see National Aeronautics and Space Administration. NASA in full National Aeronautics and Space Administration Independent U.S. for monitoring astronauts in space. InforMedix chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Bruce A. Kehr, M.D., remarked "We are delighted that through our alliance with McKesson BioServices we were able to jointly present how our solution can improve medication and protocol compliance in clinical trials. We placed the InforMedix and McKesson BioServices booths adjacent to each other to enhance our joint presentations to customer prospects including symposium participants from many premiere pharmaceutical companies." Clinical Supplies Support Group (CSSG), founded nine years ago by Marty Jeiven, is comprised of a group of Clinical Supplies professionals enthusiastic about sharing information, experiences, and best practices in this exciting and challenging field. CSSG is one of five such discussion groups in the country. CSSG meets four times per year and strives to provide the most expert and relevant information regarding Clinical Supplies. About InforMedix InforMedix has developed the Med-eMonitor System to provide real-time medical management and patient communications for clinical drug trials. InforMedix has integrated a portable patient-interactive monitoring device, hardware, software and networked communications system In telecommunication, a communications system is a collection of individual communications networks, transmission systems, relay stations, tributary stations, and data terminal equipment (DTE) usually capable of interconnection and interoperation to form an integrated whole. to enable pharmaceutical and biotechnology companies, and medical researchers to efficiently monitor and manage patients' medication compliance, protocol adherence, clinical response, and safety. Med-eMonitor is specifically designed to improve patient medication compliance and protocol adherence in clinical drug trials. The Med-eMonitor System leverages InforMedix's strong intellectual property consisting of 15 issued patents and 14 patents pending. InforMedix's patents have been cited as prior art by patent examiners in over 150 other issued patents. To find out more about InforMedix, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : IFMX), visit our website at www.informedix.com. About McKesson BioServices Understanding the critical drug development process, McKesson BioServices experienced staff has extensive domestic and worldwide shipping expertise working closely with clients to support any clinical trial and address special needs involved in handling clinical trial material. McKesson BioServices is a leader in the management, packaging and labeling, analytical testing, validation testing, storage and distribution of clinical trial materials and biological specimens covering preclinical through Phase IV studies. BioServices also provides patient-specific pharmacy services nationwide to support patient assistance programs for commercial pharmaceutical products. For information about McKesson BioServices' wide array of services, visit www.mckessonbio.com. Our parent company, McKesson Corporation is a Fortune 16 healthcare services and information technology company dedicated to helping its customers deliver high-quality healthcare by reducing costs, streamlining processes and improving the quality and safety of patient care. Over the course of its 170 year history, McKesson has grown to provide pharmaceutical and medical-surgical supply management across the spectrum of care; healthcare information technology for hospitals, physicians, homecare and payors; hospital and retail pharmacy automation; and services for manufacturers and payors designed to improve outcomes for patients. For more information, visit www.mckesson.com. InforMedix Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Provisions This report contains "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbors created thereby. These statements include the first clinical study to use this integrated solution, was recently announced, a pioneering study of remote rural diabetic patients that will monitor their responses to medication, including the relationship between medication compliance, blood glucose and HbA1c levels, at St. Vincent Healthcare, Billings Montana. References made to the discussion of the risk factors are detailed in InforMedix's filings with the Securities and Exchange Commission, including the report on Form 10-QSB for the quarter ended June 30, 2004, their Annual Report on Form 10-KSB for the year ended December 31, 2003, their prospectus dated May 28, 2004 and their other filings with the U.S. Securities and Exchange Commission. These forward-looking statements are made only as of the date hereof, and InforMedix disclaims any obligation to update or revise the information contained in any such forward-looking statements, whether as a result of new information, future events or otherwise. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion